| Subscribe To Our Free Newsletter |
Cipla faces challenges of slow growth, drug launch; analysts slash target
Shares of pharmaceutical giant Cipla dipped 5 per cent at Rs 1,403 per share on the NSE in Wednesday's intraday deals
